Amresh Kumar - 14 Jul 2023 Form 4 Insider Report for Acasti Pharma Inc. (GRCE)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ACST	Stock Options (Right to Buy)	Award	$0	+42,000		$0.000000	42,000	14 Jul 2023	Class A Common Shares	42,000	$2.64	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Stock options granted on 07/14/2023 under the Acasti Pharma Stock Option Plan, which vest and become exercisable in equal quarterly installments over a period of 36 months.